Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 1:08 AM
Ignite Modification Date:
2025-12-25 @ 11:20 PM
NCT ID:
NCT01898793
Group ID:
EG003
Title:
Lead-in Cohort & Phase II (ALT-803): Maximum NK Cell/Number kg
Description:
* Lymphodepleting Preparative Regimen: Patients receive fludarabine phosphate IV over 1 hour on days -6 to -2 and cyclophosphamide IV over 2 hours on days -5 and -4.
* Donor Leukapheresis: Peripheral blood cells are collected from haploidentical related donors on Day -1.
* CIML NK Cells: Patients undergo CIML NK cell infusion on Day 0.
* Subcutaneous ALT-803 will begin approximately 4 hours after the infusion and will continue for a total of 2 doses (Days 0 and 5).
Deaths Number Affected:
8
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
8
Other Number Affected:
8
Other Number At Risk:
8
Study:
NCT01898793
Results Section:
NCT01898793
Adverse Events Module:
NCT01898793